Figure 7
From: Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
The impact of fucose and sialic acid on the pharmacokinetic and pharmacodynamic properties of pertuzumab.
Figure 7 | Scientific Reports
From: Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties
The impact of fucose and sialic acid on the pharmacokinetic and pharmacodynamic properties of pertuzumab.
